A comparison of the effects of insulin Detemir with insulin Glargine on weight gain in female adolescents and young adults with Type 1 Diabetes on a basal bolus regime
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 24 May 2017
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Registrational
- Sponsors Novo Nordisk
- 28 Jan 2016 Accrual to date is 86% according to United Kingdom Clinical Research Network record.
- 28 Jan 2016 According to United Kingdom Clinical Research Network record, Status changed from recruiting to active, no longer recruiting.
- 07 Sep 2015 Accrual to date is 85% according to United Kingdom Clinical Research Network record.